Home > Insider Trading > Filing (0001209191-15-018838)

Filing Details

Accession Number:: 0001209191-15-018838
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-25 20:36:53
Reporting Period:: 2015-02-23

Filing Date:: 2015-02-25
Accepted Time:: 2015-02-25 20:36:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1281895	Inotek Pharmaceuticals Corp	ITEK	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1287224	Pitango Venture Capital Fund Iv, L.p.	11 Hamenofim St. Bldg. B Herzliya L3 46725	No	No	Yes	No
1601182	Pitango Venture Capital Principals Fund Iv, L.p.	11 Hamenofim St. Bldg. B Herzliya L3 46725	No	No	Yes	No
1632825	Ltd. Holdings Capital G.c. Pitango	11 Hamenofim St. Bldg. B Herzliya L3 46725	No	No	Yes	No
1632827	Pitango V.c. Fund Iv, L.p.	11 Hamenofim St. Bldg. B Herzliya L3 46725	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-23	847,424	$0.00	1,042,066	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2015-02-23	38,143	$0.00	1,080,209	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2015-02-23	212,375	$6.00	1,292,584	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series AA Convertible Preferred Stock	Disposition	2015-02-23	2,676,348	$0.00	847,424	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2015-02-23	225,747	$0.00	38,143	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Consists of the following shares of Common Stock issued upon conversion of shares of Series AA Convertible Preferred Stock ("Series AA") and accrued and unpaid dividends thereon, on a 4.05783-for-1 basis, upon the closing of the Issuer's initial public offering: (i) 829,520 shares held directly by Pitango Venture Capital Fund IV L.P. ("Pitango Fund IV"), and (ii) 17,904 shares held directly by Pitango Venture Capital Fund Principals IV L.P. ("Pitango Principals IV"). The shares of Series AA had no expiration date.
Pitango V.C. Fund IV, L.P. is the General Partner of Pitango Fund IV and Pitango Principals IV, with its own General Partner being Pitango G.P. Capital Holdings Ltd., an Israeli company, owned indirectly by six individuals. These six individuals share voting and dispositive power of the Isuer's shares but none has sole voting or dispositive power of the Issuer's shares.
The outstanding principal amount and all accrued and unpaid interest under the Convertible Promissory Notes were automatically converted upon the closing of the Issuer's initial public offering into shares of Common Stock at the initial public offering price of $6.00 per share. The Convertible Promissory Notes had no expiration date. The number of shares of Common Stock as shown in column 4 of Table I consists of the following: (i) 37,337 shares held directly by Pitango Fund IV, and (ii) 806 shares held directly by Pitango Principals IV.
Consists of the following shares purchased at the Issuer's initial public offering: (i) 207,886 shares held directly by Pitango Fund IV, and (ii) 4,489 shares held directly by Pitango Principals IV.